McKesson Recalls Megestrol Acetate Oral Suspension Due to Supra-Potent Drug
McKesson is recalling 1,531 cartons of Megestrol Acetate Oral Suspension because the drug is supra-potent. The recall is voluntary and nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with significant injury/property-damage reports or structural defects are Severe. While no specific injuries are reported in the text, the 'supra-potent' nature of the drug implies a significant risk of adverse health consequences, aligning with the Severe classification for Class II recalls involving significant risks.
Plain-English summary
McKesson Corporation is voluntarily recalling 1,531 cartons of Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL. The product is distributed in 10 mL UD cups in boxes of 20 cups and is available by prescription only. The recall was initiated because the drug is supra-potent.
The affected product was manufactured by Par Pharmaceutical and distributed by McKesson Packaging Services. The recall covers lots 0116158 (expiration 4/30/19), 0113903, 0113902, and 0113901 (expiration 8/31/18). The product was distributed nationwide within the United States.
The FDA has classified this recall as Class II, which indicates a situation that might cause temporary or medically reversible adverse health consequences. Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be returned to the distributor or disposed of according to local regulations.
The recalled product
- Product
- Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, N
- Manufacturer
- Mckesson Corporation
- Category
- Drug — Oral Suspension
- Hazard
- Affected units
- 1,531
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 0116158 Exp. 4/30/19
- 0113903
- 0113902
- 0113901
- Exp. 8/31/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Mckesson Corporation
See all →- HighDrug recall: CABTREO topical gel stored at improper temperature
FDA (Drugs) · 2024-02-28
Other drug recalls
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02